OXAZEPAM Drug Record
-
OXAZEPAM chembl:CHEMBL568 Approved
Alternate Names:
TEMAZEPAM IMPURITY, OXAZEPAM- OXOZEPAM OXAZEPAM CIV SERAX WY-3498 J3.308A SERENID FTE ZAXOPAM OXAZEPAM LEDERPAM NSC-169448 TAZEPAM (+-)-OXAZEPAM (RS)-OXAZEPAM SERAX® chembl:CHEMBL568 rxcui:7781 chemidplus:604-75-1 pubchem.compound:4616 drugbank:00842 Drug Info:
FDA Approval 1965 Drug Class small molecule Drug Indications Hypnotics and Sedatives Year of Approval 1965 Drug Class hypnotics and sedatives Drug Categories benzodiazepine hypnotics and sedatives Drug Categories benzodiazepines and benzodiazepine derivatives Drug Categories drugs that are mainly renally excreted Drug Categories heterocyclic compounds, fused-ring Drug Categories ugt1a9 substrates Drug Categories ugt2b7 substrates Publications:
-
Interaction Types & Directionality:
potentiator Interaction Info:
Trial Name - Novel drug target Established target -
Interaction Types & Directionality:
potentiator Interaction Info:
Trial Name - Novel drug target Established target -
Interaction Types & Directionality:
potentiator Interaction Info:
Trial Name - Novel drug target Established target -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Trial Name - Novel drug target Established target Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Novel drug target Established target Trial Name - Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Trial Name - Novel drug target Established target Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator Direct Interaction yes Trial Name - -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator Direct Interaction yes Trial Name - -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Novel drug target Established target Trial Name - Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Novel drug target Established target Trial Name - Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Novel drug target Established target Trial Name - Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Trial Name - Novel drug target Established target Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Trial Name - Novel drug target Established target Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Trial Name - Novel drug target Established target Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
ligand positive modulator (activating) potentiator Interaction Info:
Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator Direct Interaction yes Trial Name -
Sources:
TEND TdgClinicalTrial DrugBank ChemblInteractions -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Novel drug target Established target Trial Name - Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator Direct Interaction yes -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Trial Name - Novel drug target Established target Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) potentiator Interaction Info:
Direct Interaction yes Mechanism of Interaction GABA-A receptor; anion channel positive allosteric modulator Trial Name -
-
Alternate Names:
OXAZEPAM DrugBank Drug Name 604-75-1 CAS Number Adumbran Drug Brand Drug Info:
Drug Type small molecule Drug Groups approved Drug Categories anti-anxiety agents -
Alternate Names:
OXAZEPAM Primary Drug Name Drug Info:
Drug Class hypnotics and sedatives Year of Approval 1965 Publications:
-
- Version: January-2014
Alternate Names:
Drug Info:
Drug Indications Hypnotics and Sedatives Drug Class small molecule FDA Approval 1965 Publications:
-
Alternate Names:
Drug Info:
Publications:
-
Alternate Names:
CHEMBL568 ChEMBL Drug ID Drug Info:
Publications:
-
Alternate Names:
D09LDR TTD Drug ID Drug Info:
Publications:
-
- Version: chembl_23
Alternate Names:
Drug Info:
Publications:
-
- Version: ChEMBL_27
Alternate Names:
Drug Info:
Publications: